Neurocrine Biosciences, Inc. (NBIX)

128.63 -1.47 (-1.13%) USD  |  NASDAQ  |  Feb 20, 16:00
128.61 -0.02 (-0.02%) After-Hours: 20:00
More

Neurocrine Biosciences Current Portion of Long Term Debt (Quarterly)

Current Portion of Long Term Debt (Quarterly) Chart

View Current Portion of Long Term Debt (Quarterly) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Portion of Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years

View Current Portion of Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Portion of Long Term Debt (Quarterly) Benchmarks

View Current Portion of Long Term Debt (Quarterly) Benchmarks
Start Trial
Glaukos Corp. --
Edgewise Therapeutics, Inc. Upgrade
Nuvalent, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
CapsoVision, Inc. Upgrade